ROSUVASTATIN
- Product NDC
- 49252-063
- 11-digit product format
- 492520063
- Labeler code
- 49252
- Product ID
- 49252-063_90429790-6bb4-40fe-bcb0-1121633523cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rosuvastatin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Inventia Healthcare Limited
- Application
- ANDA207653
- Marketing category
- ANDA
- Marketing start
- 2021-02-05
- Marketing end
- 0000-00-00
- Substance
- ROSUVASTATIN CALCIUM
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 49252-063 | D | Discontinued by firm | 2026-09-14 | ||
| excluded package | package | 49252-063 | 49252-063-10 | D | Discontinued by firm | 2026-09-14 | |
| excluded package | package | 49252-063 | 49252-063-12 | D | Discontinued by firm | 2026-09-14 | |
| excluded package | package | 49252-063 | 49252-063-17 | D | Discontinued by firm | 2026-09-14 | |
| excluded package | package | 49252-063 | 49252-063-18 | D | Discontinued by firm | 2026-09-14 | |
| excluded package | package | 49252-063 | 49252-063-57 | D | Discontinued by firm | 2026-09-14 | |
| excluded package | package | 49252-063 | 49252-063-61 | D | Discontinued by firm | 2026-09-14 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49252-063-17 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49252-063-61 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49252-063-57 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49252-063-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49252-063-10 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49252-063-18 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49252-063-17 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49252-063-61 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49252-063-57 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49252-063-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49252-063-10 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49252-063-18 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49252-063-17 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49252-063-61 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49252-063-57 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49252-063-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49252-063-10 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49252-063-18 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49252-063-17 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49252-063-61 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49252-063-57 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49252-063-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49252-063-10 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49252-063-18 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49252-063-17 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49252-063-61 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49252-063-57 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49252-063-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49252-063-10 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49252-063-18 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49252-063-17 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49252-063-61 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49252-063-57 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49252-063-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49252-063-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49252-063-18 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49252-063-17 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49252-063-61 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49252-063-57 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49252-063-12 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49252-063-10 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49252-063-18 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49252-063-17 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49252-063-61 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49252-063-57 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49252-063-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49252-063-10 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49252-063-18 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49252-063-17 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49252-063-61 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49252-063-57 | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207653-001 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | ||
| A207653-002 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | ||
| A207653-003 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | ||
| A207653-004 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-004 | AB | 1 | 5aa47cf7b7d7… |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49252-063-10 | 49252006310 | 30 TABLET in 1 BOTTLE (49252-063-10) | 30 tablet | 2021-02-05 | 0000-00-00 | No | No | Current |
| 49252-063-12 | 49252006312 | 90 TABLET in 1 BOTTLE (49252-063-12) | 90 tablet | 2021-02-05 | 0000-00-00 | No | No | Current |
| 49252-063-17 | 49252006317 | 500 TABLET in 1 BOTTLE (49252-063-17) | 500 tablet | 2021-02-05 | 0000-00-00 | No | No | Current |
| 49252-063-18 | 49252006318 | 1000 TABLET in 1 BOTTLE (49252-063-18) | 1000 tablet | 2021-02-05 | 0000-00-00 | No | No | Current |
| 49252-063-57 | 49252006357 | 10 BLISTER PACK in 1 CARTON (49252-063-57) > 10 TABLET in 1 BLISTER PACK | 10 blister pack | 2021-02-05 | 0000-00-00 | No | No | Current |
| 49252-063-61 | 49252006361 | 10 BLISTER PACK in 1 CARTON (49252-063-61) > 10 TABLET in 1 BLISTER PACK | 10 blister pack | 2021-02-05 | 0000-00-00 | No | No | Current |